InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Beam Therapeutics Inc.

BEAM Clue Score48
United States Fiscal year ends December CIK 0001745999 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
John M. Evans
16 Oct 2026
CEO
Sold after exercise
25,000
$23.98
$599.60K
John M. Evans
15 Oct 2026
CEO
Sold after exercise
25,000
$23.57
$589.15K
Bethany J Cavanagh
1 Oct 2026
SVP, Finance and Treasurer
Sold on a plan
187
$24.41
$4.56K
Amy Simon
27 Jul 2026
Chief Medical Officer
Sold on a plan
16,667
$25.74
$429.04K
John M. Evans
30 Jun 2026
CEO
Sold after exercise
1,900
$34.84
$66.20K
John M. Evans
30 Jun 2026
CEO
Sold after exercise
23,100
$34.26
$791.48K
Amy Simon
30 Jun 2026
Chief Medical Officer
Sold on a plan
373
$34.73
$12.95K
John M. Evans
29 Jun 2026
CEO
Sold after exercise
11,579
$35.91
$415.82K
John M. Evans
29 Jun 2026
CEO
Sold after exercise
13,421
$35.13
$471.53K
Fmr LLC
26 Jun 2026
10% owner
Sell indirect
251,488
$35.26
$8.87M
Fmr LLC
25 Jun 2026
10% owner
Sell indirect
33,372
$35.12
$1.17M
Giuseppe Ciaramella
17 Jun 2026
President
Exercised, kept
29,000
$1.03
$29.87K
Giuseppe Ciaramella
17 Jun 2026
President
Exercised, kept
6,505
$0.67
$4.36K
Giuseppe Ciaramella
1 Apr 2026
President
Sold on a plan
11,810
$24.58
$290.29K
Christine Bellon
1 Apr 2026
Chief Legal Officer
Sold on a plan
5,956
$24.58
$146.40K
Bethany J Cavanagh
1 Apr 2026
SVP, Finance and Treasurer
Sold on a plan
3,242
$24.58
$79.69K
Amy Simon
1 Apr 2026
Chief Medical Officer
Sold on a plan
6,700
$24.58
$164.69K
John M. Evans
1 Apr 2026
CEO
Sold on a plan
30,078
$24.58
$739.32K
John M. Evans
31 Mar 2026
CEO
Sold after exercise
25,000
$22.76
$569.09K
John M. Evans
30 Mar 2026
CEO
Sold after exercise
25,000
$22.37
$559.23K
Giuseppe Ciaramella
24 Feb 2026
President
Sold after exercise
35,000
$32.00
$1.12M
John M. Evans
30 Jan 2026
CEO
Sold after exercise
2,906
$29.00
$84.27K
John M. Evans
30 Jan 2026
CEO
Sold after exercise
22,094
$28.27
$624.67K
John M. Evans
29 Jan 2026
CEO
Sold after exercise
8,667
$29.74
$257.78K
John M. Evans
29 Jan 2026
CEO
Sold after exercise
16,333
$29.19
$476.80K
Christine Bellon
22 Jan 2026
Chief Legal Officer
Sold on a plan
1,371
$34.00
$46.61K
Bethany J Cavanagh
22 Jan 2026
SVP, Finance and Treasurer
Sold on a plan
6,198
$35.00
$216.93K
Bethany J Cavanagh
20 Jan 2026
SVP, Finance and Treasurer
Sold on a plan
3,034
$30.12
$91.38K
Christine Bellon
15 Jan 2026
Chief Legal Officer
Sold on a plan
559
$35.40
$19.79K
Christine Bellon
15 Jan 2026
Chief Legal Officer
Sold on a plan
15,959
$34.72
$554.07K
Christine Bellon
15 Jan 2026
Chief Legal Officer
Sold on a plan
2,111
$33.62
$70.98K
Christine Bellon
31 Dec 2025
Chief Legal Officer
Sold on a plan
1,254
$27.10
$33.98K
Sravan Kumar Emany
31 Dec 2025
Chief Financial Officer
Sold on a plan
6,294
$27.10
$170.57K

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 13
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 639,912
History held since 11 Feb 2020